Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Jiangsu Chinagreen Biological Technology Group (300970)
- 30.77
- +0.72+2.40%
Noon Break Apr 15 11:30 CST
3.77BMarket Cap992.58P/E (TTM)
30.89High29.60Low46.79KlotVolume30.05Open30.05Prev Close141.51MTurnover4.92%Turnover RatioLossP/E (Static)122.61MShares32.8452wk High2.45P/B2.93BFloat Cap12.0752wk Low36.06Limit Up95.14MShs Float49.34Historical High24.04Limit Down4.29%Range %9.07Historical Low--Dividend TTM30.24Avg Price20.09KlotAsk--Div Yield TTM100Lot Size24.41KlotBid
Jiangsu Chinagreen Biological Technology Group (300970) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 17.98%867.67M | 7.78%498.54M | 5.33%270.6M | 3.60%1.03B | -2.07%735.47M | -12.45%462.53M | -22.75%256.91M | 32.55%996.22M | 42.31%751M | 79.29%528.28M |
| Operating revenue | 17.98%867.67M | 7.78%498.54M | 5.33%270.6M | 3.60%1.03B | -2.07%735.47M | -12.45%462.53M | -22.75%256.91M | 32.55%996.22M | 42.31%751M | 79.29%528.28M |
| Other operating revenue | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | 11.10%858.24M | 10.11%560.08M | 5.25%271.31M | 11.82%1.07B | 14.40%772.48M | 20.62%508.64M | 26.47%257.78M | 40.32%959.06M | 42.58%675.26M | 38.78%421.68M |
| Operating cost | 13.09%790.1M | 11.85%515.4M | 6.14%250.58M | 12.66%970.61M | 14.95%698.63M | 19.38%460.81M | 25.33%236.08M | 36.98%861.52M | 36.59%607.78M | 33.31%385.99M |
| Operating tax surcharges | -0.23%522.8K | -6.12%329.37K | 8.62%153.13K | 36.94%757.42K | 14.17%523.98K | 33.21%350.84K | -6.68%140.98K | 3.75%553.1K | 18.07%458.95K | 11.76%263.38K |
| Operating expense | -17.33%6.63M | -15.35%4.5M | -25.08%2.23M | 14.03%10.83M | 13.29%8.02M | 26.57%5.31M | 53.79%2.98M | 72.23%9.5M | 33.52%7.08M | 21.25%4.2M |
| Administration expense | -14.47%44.03M | -13.61%30.38M | -17.36%14.6M | -4.45%67.67M | 5.17%51.48M | 48.71%35.17M | 60.98%17.67M | 60.99%70.83M | 143.82%48.95M | 122.91%23.65M |
| Financial expense | 171.13%5.57M | 637.41%3.49M | 295.53%1.86M | 5,707.10%7.94M | 193.94%2.06M | 162.94%473.87K | -17.54%-948.75K | 101.44%136.71K | 71.08%-2.19M | 86.88%-752.85K |
| -Interest expense (Financial expense) | 112.28%11.3M | 116.46%7.4M | ---- | 27.87%11.18M | 10.79%5.32M | -50.96%3.42M | ---- | 224.75%8.75M | -58.24%4.81M | -9.82%6.97M |
| -Interest Income (Financial expense) | -74.30%-5.75M | -32.15%-3.92M | ---- | 61.99%-3.28M | 53.98%-3.3M | 28.23%-2.97M | ---- | 30.55%-8.64M | 32.69%-7.17M | 48.19%-4.14M |
| Research and development | -3.42%11.37M | -8.38%5.97M | 1.22%1.88M | -11.63%14.61M | -10.66%11.77M | -21.75%6.52M | -41.98%1.86M | 17.71%16.53M | 26.40%13.18M | 45.34%8.33M |
| Credit Impairment Loss | 116.92%143.61K | 117.00%143.61K | ---- | 19.11%-1.91M | -473.01%-848.69K | -688.85%-844.73K | -43,334.33%-4.77K | -295.91%-2.36M | -46.97%227.53K | -66.57%143.46K |
| Asset Impairment Loss | 83.34%-699.21K | 84.01%-670.76K | -128.40%-9.27K | -43.32%-11.95M | -111.00%-4.2M | -3,073.67%-4.19M | --32.65K | -132.84%-8.34M | ---1.99M | ---132.15K |
| Other net revenue | 138.21%7.51M | 469.01%4.56M | -10.05%2.8M | 62.16%-3.78M | 400.57%3.15M | 71.74%802.01K | 45.51%3.11M | -177.90%-10M | -108.03%-1.05M | -95.18%466.99K |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.69%-173.78K | -135.59%-173.78K | -2,450.47%-173.78K |
| Invest income | --0 | ---- | ---- | -83.98%86.57K | -83.98%86.57K | -83.98%86.57K | ---- | -87.32%540.24K | -76.86%540.24K | -66.01%540.24K |
| Asset deal income | -145.39%-438.91K | -121.65%-269.29K | -551.08%-109.67K | 86.39%-1.48M | 97.37%-178.86K | 97.41%-121.49K | 95.83%-16.84K | -720.31%-10.89M | -914.42%-6.79M | -764.69%-4.69M |
| Other revenue | 2.59%8.5M | -8.78%5.36M | -5.89%2.91M | 2.19%11.47M | 16.16%8.29M | 23.05%5.88M | 34.75%3.1M | -20.62%11.22M | -31.89%7.14M | -41.91%4.77M |
| Operating profit | 150.04%16.94M | -25.77%-56.98M | -6.67%2.08M | -262.29%-44.09M | -145.34%-33.86M | -142.31%-45.3M | -98.29%2.23M | -66.43%27.16M | 11.15%74.69M | 21,830.00%107.07M |
| Add:Non operating Income | -13.18%373.58K | -38.01%202.12K | -75.12%63.24K | 156.25%541.71K | 4,460.57%430.27K | 3,356.18%326.08K | 2,593.78%254.14K | 15,839.81%211.4K | 851.57%9.43K | --9.43K |
| Less:Non operating expense | -4.59%464.69K | -39.91%198.19K | 206.90%182.85K | -27.20%733.79K | -15.38%487.05K | 2.67%329.84K | -81.45%59.58K | 7.10%1.01M | -9.72%575.6K | -25.33%321.26K |
| Total profit | 149.68%16.85M | -25.75%-56.97M | -19.07%1.96M | -267.92%-44.28M | -145.76%-33.92M | -142.44%-45.31M | -98.14%2.43M | -67.03%26.37M | 11.36%74.12M | 184,013.45%106.76M |
| Less:Income tax cost | -92.58%8.56K | -157.52%-44.8 | ---- | 8,153,858.43%145.14K | --115.37K | --77.88 | --61.06 | -100.00%1.78 | ---- | ---- |
| Net profit | 149.49%16.84M | -25.75%-56.97M | -19.07%1.96M | -268.47%-44.42M | -145.92%-34.03M | -142.44%-45.31M | -98.14%2.43M | -66.05%26.37M | 11.65%74.12M | 97,030.34%106.76M |
| Net profit from continuing operation | ---- | -25.75%-56.97M | ---- | -268.47%-44.42M | ---- | -142.44%-45.31M | ---- | -66.05%26.37M | ---- | 97,030.34%106.76M |
| Less:Minority Profit | -51.63%510.35K | -578.45%-3.28M | -38.98%419.63K | 178.94%3.14M | 164.16%1.06M | -30.08%-483.22K | 41.95%687.66K | -578.85%-3.98M | -206.34%-1.64M | 14.35%-371.48K |
| Net profit of parent company owners | 146.55%16.33M | -19.79%-53.69M | -11.20%1.54M | -256.73%-47.57M | -146.31%-35.09M | -141.84%-44.82M | -98.66%1.74M | -61.22%30.35M | 13.21%75.76M | 33,007.77%107.13M |
| Earning per share | ||||||||||
| Basic earning per share | 145.87%0.1384 | -16.33%-0.4467 | -50.00%0.01 | -257.69%-0.41 | -146.47%-0.3017 | -141.98%-0.384 | -98.20%0.02 | -61.19%0.26 | 13.20%0.6492 | 32,571.43%0.9148 |
| Diluted earning per share | 145.87%0.1384 | -16.33%-0.4467 | -50.00%0.01 | -257.69%-0.41 | -146.47%-0.3017 | -141.98%-0.384 | -98.20%0.02 | -61.19%0.26 | 13.20%0.6492 | 32,571.43%0.9148 |
| Other composite income | ||||||||||
| Total composite income | 149.49%16.84M | -25.75%-56.97M | -19.07%1.96M | -268.47%-44.42M | -145.92%-34.03M | -142.44%-45.31M | -98.14%2.43M | -66.05%26.37M | 11.65%74.12M | 97,030.34%106.76M |
| Total composite income of parent company owners | 146.55%16.33M | -19.79%-53.69M | -11.20%1.54M | -256.73%-47.57M | -146.31%-35.09M | -141.84%-44.82M | -98.66%1.74M | -61.22%30.35M | 13.21%75.76M | 33,007.77%107.13M |
| Total composite income of minority owners | -51.63%510.35K | -578.45%-3.28M | -38.98%419.63K | 178.94%3.14M | 164.16%1.06M | -30.08%-483.22K | 41.95%687.66K | -578.85%-3.98M | -206.34%-1.64M | 14.35%-371.48K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm